Diagnostic and Research Institute of Pathology, Diagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria.
Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale, AZ, USA.
Pathology. 2022 Apr;54(3):262-268. doi: 10.1016/j.pathol.2021.12.288. Epub 2022 Feb 25.
Incomplete gastric intestinal metaplasia (GIM) is associated with an increased risk of gastric cancer. We aimed to examine the interobserver variability of GIM subtyping (incomplete vs complete) in histological diagnosis of patients with chronic atrophic gastritis and to identify factors with potential impact on agreement. Nine international gastrointestinal expert pathologists assessed 46 cases with complete, incomplete or mixed-type GIM on scanned haematoxylin and eosin (H&E)-stained slides. Results were compared with the consensus diagnosis driven by two experts. Interobserver variability was evaluated by kappa statistics. Focusing on the predominant pattern, the agreement between each observer and the consensus diagnosis ranged from 78% to 98%. The level of agreement was moderate to almost perfect (weighted kappa=0.464-0.984). The participating pathologists reached substantial overall agreement (Fleiss' kappa=0.716, 95% confidence interval 0.677-0.755). Misclassification with potential impact on clinical decision making occurred in 5.7% of case ratings. The pattern of GIM (pure GIM versus mixed-type GIM) differed significantly between cases with high and low agreement (p=0.010), while the number of biopsy pieces per sample and the portion of mucosal surface involved by GIM did not. Pathologists who apply subtyping in daily routine performed better than those who do not (p=0.040). In conclusion, subtyping GIM on H&E-stained slides can be achieved satisfactorily with high interobserver agreement. The implementation of GIM subtyping as a risk stratifying tool in current practice guidelines by the European Society of Gastrointestinal Endoscopy (ESGE) and the American Gastroenterological Association (AGA) carries a low rate of misclassification, at least among gastrointestinal expert pathologists.
不完全型肠上皮化生(GIM)与胃癌风险增加相关。我们旨在研究慢性萎缩性胃炎患者组织学诊断中 GIM 亚型(不完全型与完全型)的观察者间变异性,并确定对一致性有潜在影响的因素。9 位国际胃肠病学专家在扫描的苏木精和伊红(H&E)染色切片上评估了 46 例完全型、不完全型或混合型 GIM 病例。结果与由两位专家驱动的共识诊断进行比较。观察者间的变异性通过kappa 统计进行评估。主要以主要模式为重点,每位观察者与共识诊断之间的一致性范围为 78%至 98%。一致性水平为中度至几乎完美(加权 kappa=0.464-0.984)。参与的病理学家达成了实质性的总体一致性(Fleiss' kappa=0.716,95%置信区间 0.677-0.755)。在 5.7%的病例评分中发生了潜在影响临床决策的分类错误。高一致性和低一致性病例之间的 GIM 模式(纯 GIM 与混合型 GIM)存在显著差异(p=0.010),而每个样本的活检块数和 GIM 涉及的黏膜表面部分没有差异。在日常工作中应用亚型分类的病理学家表现优于不应用亚型分类的病理学家(p=0.040)。总之,在 H&E 染色切片上对 GIM 进行亚型分类可以实现令人满意的高观察者间一致性。欧洲胃肠内镜学会(ESGE)和美国胃肠病学协会(AGA)在当前实践指南中实施 GIM 亚型分类作为风险分层工具,至少在胃肠病学专家病理学家中,分类错误率较低。